Sites and mechanisms of basic narcotic receptor function based on current research.

[1]  J. Hughes,et al.  THE DISTRIBUTION OF METHIONINE‐ENKEPHALIN AND LEUCINE‐ENKEPHALIN IN THE BRAIN AND PERIPHERAL TISSUES , 1997, British journal of pharmacology.

[2]  G. Aghajanian,et al.  Opiate- and alpha 2-adrenoceptor-induced hyperpolarizations of locus ceruleus neurons in brain slices: reversal by cyclic adenosine 3':5'- monophosphate analogues , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[3]  R. North,et al.  Electrophysiology of opioids. , 1983, Pharmacological reviews.

[4]  J. Farber,et al.  Naloxone administration and ventilation in awake cats , 1983, Brain Research.

[5]  J. Huidobro-Toro,et al.  Potency of three opiate antagonists to reverse the inhibitory activity of dynorphin, enkephalins and opioid-like alkaloids on the guinea pig ileum. , 1982, European journal of pharmacology.

[6]  E. Way,et al.  Pharmacologic Consequences of Calcium Interactions with Opioid Alkaloids and Peptides , 1982 .

[7]  D. Witiak,et al.  Calcium Regulation by Calcium Antagonists , 1982 .

[8]  Shigetada Nakanishi,et al.  Cloning and sequence analysis of cDNA for porcine β-neo-endorphin/dynorphin precursor , 1982, Nature.

[9]  R. Macdonald,et al.  Opioid peptides decrease calcium-dependent action potential duration of mouse dorsal root ganglion neurons in cell culture , 1982, Brain Research.

[10]  Peter H. Seeburg,et al.  Primary structure of the human Met- and Leu-enkephalin precursor and its mRNA , 1982, Nature.

[11]  P. Seeburg,et al.  Molecular cloning establishes proenkephalin as precursor of enkephalin-containing peptides , 1982, Nature.

[12]  S. Nakanishi,et al.  Cloning and sequence analysis of cDNA for bovine adrenal preproenkephalin , 1982, Nature.

[13]  E. T. Iwamoto,et al.  Multiple opioid receptors , 1981, Medicinal research reviews.

[14]  L. Hood,et al.  Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. Loh,et al.  Possible regulatory role of dynorphin on morphine- and beta-endorphin-induced analgesia. , 1981, The Journal of pharmacology and experimental therapeutics.

[16]  H. Loh,et al.  Dynorphin interaction at the κ-opiate site , 1981 .

[17]  J. Wu,et al.  Demonstration and Characterization of Opiate Inhibition of the Striatal Adenylate Cyclase , 1981, Journal of neurochemistry.

[18]  E. Way,et al.  Methionine-enkephalin antagonism and endorphin potentiation of narcotic-induced analgesia. , 1980, European journal of pharmacology.

[19]  L. Hood,et al.  Dynorphin-(1-13), an extraordinarily potent opioid peptide. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[20]  E. Way,et al.  Effect of morphine on calcium uptake by lysed synaptosomes. , 1979, The Journal of pharmacology and experimental therapeutics.

[21]  R. North,et al.  INHIBITION OF NEURONAL FIRING BY OPIATES: EVIDENCE AGAINST THE INVOLVEMENT OF CYCLIC NUCLEOTIDES , 1979, British journal of pharmacology.

[22]  Stanley N Cohen,et al.  Nucleotide sequence of cloned cDNA for bovine corticotropin-β-lipotropin precursor , 1979, Nature.

[23]  R. Harris,et al.  Effects of acute and chronic morphine treatments on calcium localization and binding in brain. , 1978, The Journal of pharmacology and experimental therapeutics.

[24]  F. Bloom,et al.  β-ENDORPHIN AND ADRENOCORTICOTROPIN ARE SECRETED CONCOMITANTLY BY THE PITUITARY GLAND , 1978 .

[25]  F. Bloom,et al.  beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland. , 1977, Science.

[26]  John Hughes,et al.  Endogenous opioid peptides: multiple agonists and receptors , 1977, Nature.

[27]  H. Loh,et al.  beta-endorphin is a potent analgesic agent. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C. Li,et al.  Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[29]  H. Morris,et al.  Identification of two related pentapeptides from the brain with potent opiate agonist activity , 1975, Nature.

[30]  M. Nirenberg,et al.  Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Nirenberg,et al.  Morphine receptors as regulators of adenylate cyclase activity. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Choh Hao Li.  Lipotropin, a New Active Peptide from Pituitary Glands , 1964, Nature.

[33]  N. Lee,et al.  Possible regulatory function of dynorphin and its clinical implications , 1984 .

[34]  A. Rezvani,et al.  K receptor activities of the three opioid peptide families. , 1983, Life sciences.

[35]  J. Holaday,et al.  6 – Neurobiology of β-Endorphin and Related Peptides , 1981 .

[36]  A. Takemori,et al.  Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. , 1979, The Journal of pharmacology and experimental therapeutics.

[37]  G. Fischbach,et al.  Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration. , 1979, Proceedings of the National Academy of Sciences of the United States of America.